NCT01745094View on ClinicalTrials.gov

A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

October 1, 2012

Primary Completion Date

July 23, 2013

Study Completion Date

July 23, 2013

Conditions
Overactive Bladder
Interventions
DRUG

mirabegron

oral

DRUG

solifenacin

oral

Trial Locations (5)

Unknown

Chūbu

Hokkaido

Kansai

Kantou

Kyushu

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT01745094 - A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients | Biotech Hunter | Biotech Hunter